{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:54:44Z","timestamp":1794340484502,"version":"4.9.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Melatonin, more commonly known as the sleep hormone, is mainly secreted by the pineal gland in dark conditions and regulates the circadian rhythm of the organism. Its intrinsic properties, including high cell permeability, the ability to easily cross both the blood\u2013brain and placenta barriers, and its role as an endogenous reservoir of free radical scavengers (with indirect extra activities), confer it beneficial uses as an adjuvant in the biomedical field. Melatonin can exert its effects by acting through specific cellular receptors on the plasma membrane, similar to other hormones, or through receptor-independent mechanisms that involve complex molecular cross talk with other players. There is increasing evidence regarding the extraordinary beneficial effects of melatonin, also via exogenous administration. Here, we summarize molecular pathways in which melatonin is considered a master regulator, with attention to cell death and inflammation mechanisms from basic, translational and clinical points of view in the context of newborn care.<\/jats:p>","DOI":"10.1038\/s41419-019-1556-7","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T06:04:10Z","timestamp":1554703450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":278,"title":["Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care"],"prefix":"10.1038","volume":"10","author":[{"given":"Anna","family":"Tarocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Caroccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Morciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz R.","family":"Wieckowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Ancora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Garani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7108-6508","authenticated-orcid":false,"given":"Paolo","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.20945\/2359-3997000000066","volume":"62","author":"FGD Amaral","year":"2018","unstructured":"Amaral, F. G. D. & Cipolla-Neto, J. A brief review about melatonin, a pineal hormone. Arch. Endocrinol. Metab. 62, 472\u2013479 (2018).","journal-title":"Arch. Endocrinol. Metab"},{"key":"1556_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-079X.2007.00463.x","volume":"43","author":"A Garcia-Navarro","year":"2007","unstructured":"Garcia-Navarro, A. et al. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J. Pineal Res. 43, 195\u2013205 (2007).","journal-title":"J. Pineal Res."},{"key":"1556_CR3","doi-asserted-by":"publisher","first-page":"18886","DOI":"10.3390\/molecules201018886","volume":"20","author":"DX Tan","year":"2015","unstructured":"Tan, D. X., Manchester, L. C., Esteban-Zubero, E., Zhou, Z. & Reiter, R. J. Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules 20, 18886\u201318906 (2015).","journal-title":"Molecules"},{"key":"1556_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","volume":"9","author":"B Claustrat","year":"2005","unstructured":"Claustrat, B., Brun, J. & Chazot, G. The basic physiology and pathophysiology of melatonin. Sleep. Med. Rev. 9, 11\u201324 (2005).","journal-title":"Sleep. Med. Rev."},{"key":"1556_CR5","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1111\/j.1742-4658.2006.05322.x","volume":"273","author":"SR Pandi-Perumal","year":"2006","unstructured":"Pandi-Perumal, S. R. et al. Melatonin: Nature\u2019s most versatile biological signal? FEBS J. 273, 2813\u20132838 (2006).","journal-title":"FEBS J."},{"key":"1556_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-079X.2006.00372.x","volume":"41","author":"RT Cheung","year":"2006","unstructured":"Cheung, R. T. et al. Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. J. Pineal Res. 41, 337\u2013343 (2006).","journal-title":"J. Pineal Res."},{"key":"1556_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/157015910792246155","volume":"8","author":"E Esposito","year":"2010","unstructured":"Esposito, E. & Cuzzocrea, S. Antiinflammatory activity of melatonin in central nervous system. Curr. Neuropharmacol. 8, 228\u2013242 (2010).","journal-title":"Curr. Neuropharmacol."},{"key":"1556_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000491859","volume":"114","author":"S Carloni","year":"2018","unstructured":"Carloni, S., Facchinetti, F., Pelizzi, N., Buonocore, G. & Balduini, W. Melatonin acts in synergy with hypothermia to reduce oxygen-glucose deprivation-induced cell death in rat hippocampus organotypic slice cultures. Neonatology 114, 364\u2013371 (2018).","journal-title":"Neonatology"},{"key":"1556_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yhbeh.2018.08.006","volume":"105","author":"LC Motta-Teixeira","year":"2018","unstructured":"Motta-Teixeira, L. C. et al. The absence of maternal pineal melatonin rhythm during pregnancy and lactation impairs offspring physical growth, neurodevelopment, and behavior. Horm. Behav. 105, 146\u2013156 (2018).","journal-title":"Horm. Behav."},{"key":"1556_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0304-4165(99)00125-7","volume":"1472","author":"DX Tan","year":"1999","unstructured":"Tan, D. X. et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta 1472, 206\u2013214 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"1556_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11154-009-9125-5","volume":"10","author":"A Chattoraj","year":"2009","unstructured":"Chattoraj, A., Liu, T., Zhang, L. S., Huang, Z. & Borjigin, J. Melatonin formation in mammals: in vivo perspectives. Rev. Endocr. Metab. Disord. 10, 237\u2013243 (2009).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"1556_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/edrv-12-2-151","volume":"12","author":"RJ Reiter","year":"1991","unstructured":"Reiter, R. J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12, 151\u2013180 (1991).","journal-title":"Endocr. Rev."},{"key":"1556_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/157016109788340749","volume":"7","author":"A Dominguez-Rodriguez","year":"2009","unstructured":"Dominguez-Rodriguez, A., Abreu-Gonzalez, P. & Reiter, R. J. Clinical aspects of melatonin in the acute coronary syndrome. Curr. Vasc. Pharmacol. 7, 367\u2013373 (2009).","journal-title":"Curr. Vasc. Pharmacol."},{"key":"1556_CR14","first-page":"1673","volume":"15","author":"R Rosen","year":"2009","unstructured":"Rosen, R. et al. Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients. Mol. Vis. 15, 1673\u20131679 (2009).","journal-title":"Mol. Vis."},{"key":"1556_CR15","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","volume":"71","author":"D Acuna-Castroviejo","year":"2014","unstructured":"Acuna-Castroviejo, D. et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell. Mol. Life Sci. 71, 2997\u20133025 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"1556_CR16","doi-asserted-by":"publisher","first-page":"1835195","DOI":"10.1155\/2017\/1835195","volume":"2017","author":"G Favero","year":"2017","unstructured":"Favero, G., Franceschetti, L., Bonomini, F., Rodella, L. F. & Rezzani, R. Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int. J. Endocrinol. 2017, 1835195 (2017).","journal-title":"Int. J. Endocrinol."},{"key":"1556_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jpi.12267","volume":"59","author":"LC Manchester","year":"2015","unstructured":"Manchester, L. C. et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J. Pineal Res. 59, 403\u2013419 (2015).","journal-title":"J. Pineal Res."},{"key":"1556_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.exger.2004.04.012","volume":"39","author":"M Karasek","year":"2004","unstructured":"Karasek, M. Melatonin, human aging, and age-related diseases. Exp. Gerontol. 39, 1723\u20131729 (2004).","journal-title":"Exp. Gerontol."},{"key":"1556_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fncel.2017.00199","volume":"11","author":"B Leaw","year":"2017","unstructured":"Leaw, B. et al. Mitochondria, bioenergetics and excitotoxicity: new therapeutic targets in perinatal brain injury. Front. Cell. Neurosci. 11, 199 (2017).","journal-title":"Front. Cell. Neurosci"},{"key":"1556_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1600-079X.1993.tb00498.x","volume":"14","author":"B Poeggeler","year":"1993","unstructured":"Poeggeler, B., Reiter, R. J., Tan, D. X., Chen, L. D. & Manchester, L. C. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J. Pineal Res. 14, 151\u2013168 (1993).","journal-title":"J. Pineal Res."},{"key":"1556_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/jpi.12026","volume":"54","author":"DX Tan","year":"2013","unstructured":"Tan, D. X. et al. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin\u2019s primary function and evolution in eukaryotes. J. Pineal Res. 54, 127\u2013138 (2013).","journal-title":"J. Pineal Res."},{"key":"1556_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1385\/ENDO:27:2:111","volume":"27","author":"GR Martinez","year":"2005","unstructured":"Martinez, G. R. et al. Measurement of melatonin and its metabolites: importance for the evaluation of their biological roles. Endocrine 27, 111\u2013118 (2005).","journal-title":"Endocrine"},{"key":"1556_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1600-079X.2005.00248.x","volume":"39","author":"C Tomas-Zapico","year":"2005","unstructured":"Tomas-Zapico, C. & Coto-Montes, A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res. 39, 99\u2013104 (2005).","journal-title":"J. Pineal Res."},{"key":"1556_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/074873049701200606","volume":"12","author":"SM Reppert","year":"1997","unstructured":"Reppert, S. M. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J. Biol. Rhythms 12, 528\u2013531 (1997).","journal-title":"J. Biol. Rhythms"},{"key":"1556_CR25","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1111\/bph.13536","volume":"173","author":"R Jockers","year":"2016","unstructured":"Jockers, R. et al. Update on melatonin receptors: IUPHAR Review 20. Br. J. Pharmacol. 173, 2702\u20132725 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"1556_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1517\/14728222.2016.1091882","volume":"20","author":"JA Boutin","year":"2016","unstructured":"Boutin, J. A. Quinone reductase 2 as a promising target of melatonin therapeutic actions. Expert. Opin. Ther. Targets. 20, 303\u2013317 (2016).","journal-title":"Expert. Opin. Ther. Targets."},{"key":"1556_CR27","doi-asserted-by":"publisher","first-page":"d1093","DOI":"10.2741\/1089","volume":"8","author":"ML Dubocovich","year":"2003","unstructured":"Dubocovich, M. L., Rivera-Bermudez, M. A., Gerdin, M. J. & Masana, M. I. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front. Biosci. 8, d1093\u2013d1108 (2003).","journal-title":"Front. Biosci."},{"key":"1556_CR28","doi-asserted-by":"crossref","first-page":"28531","DOI":"10.1016\/S0021-9258(19)61934-4","volume":"269","author":"M Becker-Andre","year":"1994","unstructured":"Becker-Andre, M. et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269, 28531\u201328534 (1994).","journal-title":"J. Biol. Chem."},{"key":"1556_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1124\/pr.110.002832","volume":"62","author":"ML Dubocovich","year":"2010","unstructured":"Dubocovich, M. L. et al. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol. Rev. 62, 343\u2013380 (2010).","journal-title":"Pharmacol. Rev."},{"key":"1556_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0165-0327(00)00270-6","volume":"65","author":"T Paparrigopoulos","year":"2001","unstructured":"Paparrigopoulos, T. et al. Melatonin response to clonidine administration in depression: indication of presynaptic alpha2-adrenoceptor dysfunction. J. Affect. Disord. 65, 307\u2013313 (2001).","journal-title":"J. Affect. Disord."},{"key":"1556_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2016.11.045","volume":"102","author":"SM Raefsky","year":"2017","unstructured":"Raefsky, S. M. & Mattson, M. P. Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance. Free Radic. Biol. Med. 102, 203\u2013216 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"1556_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death. Differ. 25, 486\u2013541 (2018).","journal-title":"Cell Death. Differ."},{"key":"1556_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nbd.2007.06.009","volume":"27","author":"S Carloni","year":"2007","unstructured":"Carloni, S., Carnevali, A., Cimino, M. & Balduini, W. Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat. Neurobiol. Dis. 27, 354\u2013361 (2007).","journal-title":"Neurobiol. Dis."},{"key":"1556_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuroscience.2007.06.060","volume":"149","author":"FJ Northington","year":"2007","unstructured":"Northington, F. J. et al. Failure to complete apoptosis following neonatal hypoxia-ischemiamanifests as \"continuum\" phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience 149, 822\u2013833 (2007).","journal-title":"Neuroscience"},{"key":"1556_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1089\/08977150260190410","volume":"19","author":"J Lok","year":"2002","unstructured":"Lok, J. & Martin, L. J. Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J. Neurotrauma 19, 815\u2013828 (2002).","journal-title":"J. Neurotrauma"},{"key":"1556_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/boc.201600019","volume":"108","author":"G Morciano","year":"2016","unstructured":"Morciano, G. et al. Intersection of mitochondrial fission and fusion machinery with apoptotic pathways: role of Mcl-1. Biol. Cell 108, 279\u2013293 (2016).","journal-title":"Biol. Cell"},{"key":"1556_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1034\/j.1600-079X.2002.01891.x","volume":"33","author":"FY Sun","year":"2002","unstructured":"Sun, F. Y. et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J. Pineal Res. 33, 48\u201356 (2002).","journal-title":"J. Pineal Res."},{"key":"1556_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000047087","volume":"79","author":"X Wang","year":"2001","unstructured":"Wang, X. et al. Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia. Biol. Neonate 79, 172\u2013179 (2001).","journal-title":"Biol. Neonate"},{"key":"1556_CR39","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/00004647-200009000-00003","volume":"20","author":"BR Hu","year":"2000","unstructured":"Hu, B. R., Liu, C. L., Ouyang, Y., Blomgren, K. & Siesjo, B. K. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J. Cereb. Blood Flow Metab. 20, 1294\u20131300 (2000).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1556_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1600-079X.2003.00115.x","volume":"36","author":"E Kilic","year":"2004","unstructured":"Kilic, E., Kilic, U., Yulug, B., Hermann, D. M. & Reiter, R. J. Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator. J. Pineal Res. 36, 171\u2013176 (2004).","journal-title":"J. Pineal Res."},{"key":"1556_CR41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-079X.2007.00495.x","volume":"44","author":"PO Koh","year":"2008","unstructured":"Koh, P. O. Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J. Pineal Res. 44, 101\u2013106 (2008).","journal-title":"J. Pineal Res."},{"key":"1556_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-079X.2005.00283.x","volume":"40","author":"SH Lee","year":"2006","unstructured":"Lee, S. H. et al. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J. Pineal Res. 40, 79\u201385 (2006).","journal-title":"J. Pineal Res."},{"key":"1556_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-319-55330-6_9","volume":"982","author":"G Morciano","year":"2017","unstructured":"Morciano, G. et al. Mechanistic role of mPTP in ischemia-reperfusion injury. Adv. Exp. Med. Biol. 982, 169\u2013189 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1556_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.yjmcc.2014.08.015","volume":"78","author":"G Morciano","year":"2015","unstructured":"Morciano, G. et al. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 78, 142\u2013153 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1556_CR45","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.15252\/embr.201643602","volume":"18","author":"M Bonora","year":"2017","unstructured":"Bonora, M. et al. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. EMBO Rep. 18, 1077\u20131089 (2017).","journal-title":"EMBO Rep."},{"key":"1556_CR46","doi-asserted-by":"publisher","first-page":"674","DOI":"10.4161\/cc.23599","volume":"12","author":"M Bonora","year":"2013","unstructured":"Bonora, M. et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12, 674\u2013683 (2013).","journal-title":"Cell Cycle"},{"key":"1556_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41569-018-0074-0","volume":"16","author":"M Bonora","year":"2018","unstructured":"Bonora, M. et al. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nat. Rev. Cardiol 16, 33\u201355 (2018).","journal-title":"Nat. Rev. Cardiol"},{"key":"1556_CR48","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.1021\/acs.jmedchem.8b00278","volume":"61","author":"G Morciano","year":"2018","unstructured":"Morciano, G. et al. Discovery of novel 1,3,8-Triazaspiro[4.5]decane derivatives that target the c subunit of F1\/FO-adenosine triphosphate (ATP) synthase for the treatment of reperfusion damage in myocardial infarction. J. Med. Chem. 61, 7131\u20137143 (2018).","journal-title":"J. Med. Chem."},{"key":"1556_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2016.08.005","volume":"31","author":"M Waseem","year":"2016","unstructured":"Waseem, M., Tabassum, H. & Parvez, S. Melatonin modulates permeability transition pore and 5-hydroxydecanoate induced KATP channel inhibition in isolated brain mitochondria. Mitochondrion 31, 1\u20138 (2016).","journal-title":"Mitochondrion"},{"key":"1556_CR50","doi-asserted-by":"publisher","first-page":"e12503","DOI":"10.1111\/jpi.12503","volume":"65","author":"H Zhou","year":"2018","unstructured":"Zhou, H. et al. Inhibitory effect of melatonin on necroptosis via repressing the Ripk3-PGAM5-CypD-mPTP pathway attenuates cardiac microvascular ischemia-reperfusion injury. J. Pineal Res. 65, e12503 (2018).","journal-title":"J. Pineal Res."},{"key":"1556_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1085\/jgp.201511526","volume":"147","author":"H Yu","year":"2016","unstructured":"Yu, H., Dickson, E. J., Jung, S. R., Koh, D. S. & Hille, B. High membrane permeability for melatonin. J. Gen. Physiol. 147, 63\u201376 (2016).","journal-title":"J. Gen. Physiol."},{"issue":"4","key":"1556_CR52","doi-asserted-by":"publisher","first-page":"e12390","DOI":"10.1111\/jpi.12390","volume":"62","author":"Xiaokui Huo","year":"2017","unstructured":"Huo, X. et al. Human transporters, PEPT1\/2, facilitate melatonin transportation into mitochondria of cancer cells: an implication of the therapeutic potential. J. Pineal Res. 62, e12390 (2017).","journal-title":"Journal of Pineal Research"},{"key":"1556_CR53","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s00018-017-2616-8","volume":"74","author":"JC Mayo","year":"2017","unstructured":"Mayo, J. C., Sainz, R. M., Gonzalez-Menendez, P., Hevia, D. & Cernuda-Cernuda, R. Melatonin transport into mitochondria. Cell. Mol. Life. Sci. 74, 3927\u20133940 (2017).","journal-title":"Cell. Mol. Life. Sci."},{"key":"1556_CR54","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.freeradbiomed.2009.06.032","volume":"47","author":"G Petrosillo","year":"2009","unstructured":"Petrosillo, G., Moro, N., Ruggiero, F. M. & Paradies, G. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic. Biol. Med. 47, 969\u2013974 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"1556_CR55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1096\/fj.03-1031fje","volume":"18","author":"SA Andrabi","year":"2004","unstructured":"Andrabi, S. A., Sayeed, I., Siemen, D., Wolf, G. & Horn, T. F. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J. 18, 869\u2013871 (2004).","journal-title":"FASEB J."},{"issue":"1","key":"1556_CR56","doi-asserted-by":"publisher","first-page":"e12443","DOI":"10.1111\/jpi.12443","volume":"64","author":"Bharati Sinha","year":"2017","unstructured":"Sinha, B. et al. Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor. J. Pineal Res. 64, e12443 (2018).","journal-title":"Journal of Pineal Research"},{"issue":"1","key":"1556_CR57","doi-asserted-by":"publisher","first-page":"e12413","DOI":"10.1111\/jpi.12413","volume":"63","author":"Hao Zhou","year":"2017","unstructured":"Zhou, H. et al. Melatonin protects cardiac microvasculature against ischemia\/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J. Pineal Res. 63, e12413 (2017).","journal-title":"Journal of Pineal Research"},{"key":"1556_CR58","doi-asserted-by":"publisher","first-page":"6024959","DOI":"10.1155\/2017\/6024959","volume":"2017","author":"V Fineschi","year":"2017","unstructured":"Fineschi, V., Viola, R. V., La Russa, R., Santurro, A. & Frati, P. A Controversial Medicolegal Issue: timing the onset of perinatal hypoxic-ischemic brain injury. Mediators Inflamm. 2017, 6024959 (2017).","journal-title":"Mediators Inflamm."},{"key":"1556_CR59","doi-asserted-by":"crossref","unstructured":"Carloni, S., Riparini, G., Buonocore, G. & Balduini, W. Rapid modulation of the silent information regulator 1 by melatonin after hypoxia-ischemia in the neonatal rat brain. J. Pineal Res. 63, e12434 (2017).","DOI":"10.1111\/jpi.12434"},{"key":"1556_CR60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neulet.2016.11.050","volume":"653","author":"Y Hu","year":"2017","unstructured":"Hu, Y. et al. Melatonin reduces hypoxic-ischaemic (HI) induced autophagy and apoptosis: an in vivo and in vitro investigation in experimental models of neonatal HI brain injury. Neurosci. Lett. 653, 105\u2013112 (2017).","journal-title":"Neurosci. Lett."},{"key":"1556_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4161\/auto.5.2.7363","volume":"5","author":"W Balduini","year":"2009","unstructured":"Balduini, W., Carloni, S. & Buonocore, G. Autophagy in hypoxia-ischemia induced brain injury: evidence and speculations. Autophagy 5, 221\u2013223 (2009).","journal-title":"Autophagy"},{"key":"1556_CR62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2008.07.022","volume":"32","author":"S Carloni","year":"2008","unstructured":"Carloni, S., Buonocore, G. & Balduini, W. Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol. Dis. 32, 329\u2013339 (2008).","journal-title":"Neurobiol. Dis."},{"key":"1556_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000356647","volume":"33","author":"JW Kang","year":"2014","unstructured":"Kang, J. W., Cho, H. I. & Lee, S. M. Melatonin inhibits mTOR-dependent autophagy during liver ischemia\/reperfusion. Cell Physiol. Biochem. 33, 23\u201336 (2014).","journal-title":"Cell Physiol. Biochem."},{"key":"1556_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jpi.12247","volume":"59","author":"B San-Miguel","year":"2015","unstructured":"San-Miguel, B. et al. Melatonin inhibits autophagy and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis. J. Pineal Res. 59, 151\u2013162 (2015).","journal-title":"J. Pineal Res."},{"key":"1556_CR65","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1254\/jphs.13220FP","volume":"124","author":"Y Zheng","year":"2014","unstructured":"Zheng, Y. et al. Inhibition of autophagy contributes to melatonin-mediated neuroprotection against transient focal cerebral ischemia in rats. J. Pharmacol. Sci. 124, 354\u2013364 (2014).","journal-title":"J. Pharmacol. Sci."},{"key":"1556_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jpi.12086","volume":"56","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage. J. Pineal Res. 56, 12\u201319 (2014).","journal-title":"J. Pineal Res."},{"key":"1556_CR67","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neuint.2015.10.008","volume":"91","author":"K Ding","year":"2015","unstructured":"Ding, K. et al. Melatonin protects the brain from apoptosis by enhancement of autophagy after traumatic brain injury in mice. Neurochem. Int. 91, 46\u201354 (2015).","journal-title":"Neurochem. Int."},{"key":"1556_CR68","doi-asserted-by":"crossref","unstructured":"Areti, A., Komirishetty, P., Akuthota, M., Malik, R. A. & Kumar, A. Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy. J. Pineal Res. 62, e12393 (2017).","DOI":"10.1111\/jpi.12393"},{"key":"1556_CR69","doi-asserted-by":"publisher","first-page":"e12534","DOI":"10.1111\/jpi.12534","volume":"66","author":"JA Boga","year":"2018","unstructured":"Boga, J. A. et al. Therapeutic potential of melatonin related to its role as an autophagy regulator: A review. J. Pineal Res. 66, e12534 (2018).","journal-title":"J. Pineal Res."},{"issue":"3","key":"1556_CR70","doi-asserted-by":"publisher","first-page":"e12389","DOI":"10.1111\/jpi.12389","volume":"62","author":"Zhengwang Cao","year":"2017","unstructured":"Cao, Z. et al. Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J. Pineal Res. 62, e12389 (2017).","journal-title":"Journal of Pineal Research"},{"key":"1556_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jpi.12300","volume":"60","author":"Y Dong","year":"2016","unstructured":"Dong, Y. et al. Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling. J. Pineal Res. 60, 253\u2013262 (2016).","journal-title":"J. Pineal Res."},{"key":"1556_CR72","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fphar.2017.00278","volume":"8","author":"G Fenini","year":"2017","unstructured":"Fenini, G., Contassot, E. & French, L. E. Potential of IL-1, IL-18 and inflammasome inhibition for the treatment of inflammatory skin diseases. Front. Pharmacol. 8, 278 (2017).","journal-title":"Front. Pharmacol."},{"key":"1556_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-079X.2012.01014.x","volume":"54","author":"JL Mauriz","year":"2013","unstructured":"Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J. & Gonzalez-Gallego, J. A review of the molecular aspects of melatonin\u2019s anti-inflammatory actions: recent insights and new perspectives. J. Pineal Res. 54, 1\u201314 (2013).","journal-title":"J. Pineal Res."},{"key":"1556_CR74","doi-asserted-by":"publisher","first-page":"e0178525","DOI":"10.1371\/journal.pone.0178525","volume":"12","author":"GM Yu","year":"2017","unstructured":"Yu, G. M., Kubota, H., Okita, M. & Maeda, T. The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells. PLoS ONE 12, e0178525 (2017).","journal-title":"PLoS ONE"},{"key":"1556_CR75","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neulet.2008.05.036","volume":"439","author":"J Tocharus","year":"2008","unstructured":"Tocharus, J., Chongthammakun, S. & Govitrapong, P. Melatonin inhibits amphetamine-induced nitric oxide synthase mRNA overexpression in microglial cell lines. Neurosci. Lett. 439, 134\u2013137 (2008).","journal-title":"Neurosci. Lett."},{"key":"1556_CR76","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1182\/blood-2005-09-3691","volume":"108","author":"WG Deng","year":"2006","unstructured":"Deng, W. G., Tang, S. T., Tseng, H. P. & Wu, K. K. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108, 518\u2013524 (2006).","journal-title":"Blood"},{"key":"1556_CR77","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1600-079X.2008.00657.x","volume":"46","author":"EK Tamura","year":"2009","unstructured":"Tamura, E. K., Cecon, E., Monteiro, A. W., Silva, C. L. & Markus, R. P. Melatonin inhibits LPS-induced NO production in rat endothelial cells. J. Pineal Res. 46, 268\u2013274 (2009).","journal-title":"J. Pineal Res"},{"key":"1556_CR78","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1096\/fj.15-273656","volume":"29","author":"JA Garcia","year":"2015","unstructured":"Garcia, J. A. et al. Disruption of the NF-kappaB\/NLRP3 connection by melatonin requires retinoid-related orphan receptor-alpha and blocks the septic response in mice. FASEB J. 29, 3863\u20133875 (2015).","journal-title":"FASEB J."},{"issue":"1","key":"1556_CR79","doi-asserted-by":"publisher","first-page":"e12410","DOI":"10.1111\/jpi.12410","volume":"63","author":"Ibtissem Rahim","year":"2017","unstructured":"Rahim, I. et al. Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis. J. Pineal Res. 63, e12410 (2017).","journal-title":"Journal of Pineal Research"},{"key":"1556_CR80","doi-asserted-by":"crossref","unstructured":"Liu, Z. et al. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-kappaB\/GSDMD signal in mice adipose tissue. J. Pineal Res. 63, e12414 (2017).","DOI":"10.1111\/jpi.12414"},{"key":"1556_CR81","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1194\/jlr.M038638","volume":"54","author":"A Giordano","year":"2013","unstructured":"Giordano, A. et al. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J. Lipid Res. 54, 2423\u20132436 (2013).","journal-title":"J. Lipid Res."},{"key":"1556_CR82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jpi.12303","volume":"60","author":"H Volt","year":"2016","unstructured":"Volt, H. et al. Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin. J. Pineal Res. 60, 193\u2013205 (2016).","journal-title":"J. Pineal Res."},{"key":"1556_CR83","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.brainresbull.2004.09.008","volume":"64","author":"S Shavali","year":"2005","unstructured":"Shavali, S. et al. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res. Bull. 64, 471\u2013479 (2005).","journal-title":"Brain Res. Bull."},{"key":"1556_CR84","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0149-7634(95)00052-6","volume":"20","author":"DA Golombek","year":"1996","unstructured":"Golombek, D. A., Pevet, P. & Cardinali, D. P. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci. Biobehav. Rev. 20, 403\u2013412 (1996).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1556_CR85","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/157015912800604489","volume":"10","author":"V Srinivasan","year":"2012","unstructured":"Srinivasan, V. et al. Melatonin in antinociception: its therapeutic applications. Curr. Neuropharmacol. 10, 167\u2013178 (2012).","journal-title":"Curr. Neuropharmacol."},{"key":"1556_CR86","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.brainresbull.2009.12.001","volume":"81","author":"V Srinivasan","year":"2010","unstructured":"Srinivasan, V. et al. Potential use of melatonergic drugs in analgesia: mechanisms of action. Brain Res. Bull. 81, 362\u2013371 (2010).","journal-title":"Brain Res. Bull."},{"key":"1556_CR87","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1600-079X.2006.00380.x","volume":"41","author":"M Mantovani","year":"2006","unstructured":"Mantovani, M. et al. Mechanisms involved in the antinociception caused by melatonin in mice. J. Pineal Res. 41, 382\u2013389 (2006).","journal-title":"J. Pineal Res."},{"key":"1556_CR88","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0304-3940(00)00883-1","volume":"282","author":"CX Yu","year":"2000","unstructured":"Yu, C. X., Zhu, C. B., Xu, S. F., Cao, X. D. & Wu, G. C. Selective MT(2) melatonin receptor antagonist blocks melatonin-induced antinociception in rats. Neurosci. Lett. 282, 161\u2013164 (2000).","journal-title":"Neurosci. Lett."},{"key":"1556_CR89","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00001756-200201210-00021","volume":"13","author":"C Laurido","year":"2002","unstructured":"Laurido, C. et al. Effect of melatonin on rat spinal cord nociceptive transmission. Neuroreport 13, 89\u201391 (2002).","journal-title":"Neuroreport"},{"key":"1556_CR90","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41580-018-0066-2","volume":"19","author":"C Giorgi","year":"2018","unstructured":"Giorgi, C., Marchi, S. & Pinton, P. Publisher Correction: The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 19, 746 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1556_CR91","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.tcb.2018.01.002","volume":"28","author":"C Giorgi","year":"2018","unstructured":"Giorgi, C., Danese, A., Missiroli, S., Patergnani, S. & Pinton, P. Calcium dynamics as a machine for decoding signals. Trends Cell Biol. 28, 258\u2013273 (2018).","journal-title":"Trends Cell Biol."},{"key":"1556_CR92","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0143-4160(03)00141-6","volume":"34","author":"M Arundine","year":"2003","unstructured":"Arundine, M. & Tymianski, M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34, 325\u2013337 (2003).","journal-title":"Cell Calcium"},{"key":"1556_CR93","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1016\/j.pain.2012.08.016","volume":"153","author":"S Wang","year":"2012","unstructured":"Wang, S. et al. Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors. Pain 153, 2448\u20132457 (2012).","journal-title":"Pain"},{"key":"1556_CR94","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1365-2826.2001.00656.x","volume":"13","author":"G Escames","year":"2001","unstructured":"Escames, G. et al. Calcium-dependent effects of melatonin inhibition of glutamatergic response in rat striatum. J. Neuroendocrinol. 13, 459\u2013466 (2001).","journal-title":"J. Neuroendocrinol."},{"key":"1556_CR95","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF02976433","volume":"22","author":"HJ Kim","year":"1999","unstructured":"Kim, H. J. & Kwon, J. S. Effects of placing micro-implants of melatonin in striatum on oxidative stress and neuronal damage mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. Arch. Pharm. Res. 22, 35\u201343 (1999).","journal-title":"Arch. Pharm. Res."},{"key":"1556_CR96","doi-asserted-by":"publisher","first-page":"e7128","DOI":"10.1371\/journal.pone.0007128","volume":"4","author":"P Olivier","year":"2009","unstructured":"Olivier, P. et al. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS ONE 4, e7128 (2009).","journal-title":"PLoS ONE"},{"key":"1556_CR97","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/j.1651-2227.2007.00496.x","volume":"96","author":"NF Padilla-Gomes","year":"2007","unstructured":"Padilla-Gomes, N. F. et al. Prevalence of neonatal ultrasound brain lesions in premature infants with and without intrauterine growth restriction. Acta Paediatr. 96, 1582\u20131587 (2007).","journal-title":"Acta Paediatr."},{"key":"1556_CR98","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000087586","volume":"88","author":"OD Saugstad","year":"2005","unstructured":"Saugstad, O. D. Oxidative stress in the newborn\u2014a 30-year perspective. Biol. Neonate 88, 228\u2013236 (2005).","journal-title":"Biol. Neonate"},{"key":"1556_CR99","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000337345","volume":"101","author":"OD Saugstad","year":"2012","unstructured":"Saugstad, O. D., Sejersted, Y., Solberg, R., Wollen, E. J. & Bjoras, M. Oxygenation of the newborn: a molecular approach. Neonatology 101, 315\u2013325 (2012).","journal-title":"Neonatology"},{"key":"1556_CR100","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jfma.2011.11.024","volume":"111","author":"YC Chen","year":"2012","unstructured":"Chen, Y. C., Tain, Y. L., Sheen, J. M. & Huang, L. T. Melatonin utility in neonates and children. J. Formos Med. Assoc. 111, 57\u201366 (2012).","journal-title":"J. Formos Med. Assoc"},{"key":"1556_CR101","doi-asserted-by":"publisher","first-page":"980374","DOI":"10.1155\/2013\/980374","volume":"2013","author":"E Gitto","year":"2013","unstructured":"Gitto, E. et al. Protective role of melatonin in neonatal diseases. Oxid. Med. Cell. Longev. 2013, 980374 (2013).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1556_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.earlhumdev.2018.08.012","volume":"126","author":"H McKenna","year":"2018","unstructured":"McKenna, H. & Reiss, I. K. M. The case for a chronobiological approach to neonatal care. Early Hum. Dev. 126, 1\u20135 (2018).","journal-title":"Early Hum. Dev."},{"key":"1556_CR103","doi-asserted-by":"publisher","first-page":"9390140","DOI":"10.1155\/2018\/9390140","volume":"2018","author":"C Poggi","year":"2018","unstructured":"Poggi, C. & Dani, C. Sepsis and oxidative stress in the newborn: from pathogenesis to novel therapeutic targets. Oxid. Med. Cell. Longev 2018, 9390140 (2018).","journal-title":"Oxid. Med. Cell. Longev"},{"key":"1556_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5935\/0103-507X.20180005","volume":"30","author":"DC de Souza","year":"2018","unstructured":"de Souza, D. C., Brandao, M. B. & Piva, J. P. From the International Pediatric Sepsis Conference 2005 to the Sepsis-3 Consensus. Rev. Bras. Ter. Intensiva. 30, 1\u20135 (2018).","journal-title":"Rev. Bras. Ter. Intensiva."},{"key":"1556_CR105","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/SHK.0000000000000198","volume":"42","author":"M Bajcetic","year":"2014","unstructured":"Bajcetic, M., Spasic, S. & Spasojevic, I. Redox therapy in neonatal sepsis: reasons, targets, strategy, and agents. Shock 42, 179\u2013184 (2014).","journal-title":"Shock"},{"key":"1556_CR106","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3109\/14767058.2015.1107898","volume":"29","author":"AR El-Mashad","year":"2016","unstructured":"El-Mashad, A. R., Elmahdy, H., El-Dib, M., Elbatch, M. & Aly, H. Can melatonin be used as a marker for neonatal sepsis? J. Matern. Fetal Neonatal Med. 29, 2870\u20132873 (2016).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1556_CR107","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/NPM-15814072","volume":"8","author":"M El Frargy","year":"2015","unstructured":"El Frargy, M., El-Sharkawy, H. M. & Attia, G. F. Use of melatonin as an adjuvant therapy in neonatal sepsis. J. Neonatal Perinatal Med. 8, 227\u2013232 (2015).","journal-title":"J. Neonatal Perinatal Med"},{"key":"1556_CR108","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1080\/14767058.2017.1342794","volume":"31","author":"FM El-Gendy","year":"2018","unstructured":"El-Gendy, F. M., El-Hawy, M. A. & Hassan, M. G. Beneficial effect of melatonin in the treatment of neonatal sepsis. J. Matern. Fetal Neonatal Med. 31, 2299\u20132303 (2018).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1556_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ctim.2018.06.002","volume":"39","author":"R Henderson","year":"2018","unstructured":"Henderson, R., Kim, S. & Lee, E. Use of melatonin as adjunctive therapy in neonatal sepsis: a systematic review and meta-analysis. Complement. Ther. Med. 39, 131\u2013136 (2018).","journal-title":"Complement. Ther. Med."},{"key":"1556_CR110","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/14767058.2011.573827","volume":"25","author":"S Aversa","year":"2012","unstructured":"Aversa, S., Pellegrino, S., Barberi, I., Reiter, R. J. & Gitto, E. Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J. Matern. Fetal Neonatal Med. 25, 207\u2013221 (2012).","journal-title":"J. Matern. Fetal Neonatal Med"},{"key":"1556_CR111","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.earlhumdev.2014.12.012","volume":"91","author":"D Katzer","year":"2015","unstructured":"Katzer, D. et al. Antioxidative status and oxidative stress in the fetal circulation at birth: the effects of time of delivery and presence of labor. Early Hum. Dev. 91, 119\u2013124 (2015).","journal-title":"Early Hum. Dev."},{"issue":"Suppl 3","key":"1556_CR112","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/14767058.2010.509940","volume":"23","author":"S Perrone","year":"2010","unstructured":"Perrone, S., Negro, S., Tataranno, M. L. & Buonocore, G. Oxidative stress and antioxidant strategies in newborns. J. Matern Fetal Neonatal Med. 23(Suppl 3), 63\u201365 (2010).","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"1556_CR113","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-079X.2006.00398.x","volume":"42","author":"JE Jan","year":"2007","unstructured":"Jan, J. E., Wasdell, M. B., Freeman, R. D. & Bax, M. Evidence supporting the use of melatonin in short gestation infants. J. Pineal Res. 42, 22\u201327 (2007).","journal-title":"J. Pineal Res."},{"key":"1556_CR114","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.arcped.2015.05.019","volume":"22","author":"C Yzydorczyk","year":"2015","unstructured":"Yzydorczyk, C. et al. [Oxidative stress after preterm birth: origins, biomarkers, and possible therapeutic approaches]. Arch. Pediatr. 22, 1047\u20131055 (2015).","journal-title":"Arch. Pediatr."},{"key":"1556_CR115","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1600-079X.2011.00941.x","volume":"52","author":"E Gitto","year":"2012","unstructured":"Gitto, E. et al. Pain in neonatal intensive care: role of melatonin as an analgesic antioxidant. J. Pineal Res. 52, 291\u2013295 (2012).","journal-title":"J. Pineal Res."},{"key":"1556_CR116","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1055\/s-0035-1547328","volume":"32","author":"L Marseglia","year":"2015","unstructured":"Marseglia, L. et al. Oxidative stress-mediated damage in newborns with necrotizing enterocolitis: a possible role of melatonin. Am. J. Perinatol. 32, 905\u2013909 (2015).","journal-title":"Am. J. Perinatol."},{"key":"1556_CR117","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jpi.12292","volume":"60","author":"A Pazar","year":"2016","unstructured":"Pazar, A. et al. The neuroprotective and anti-apoptotic effects of melatonin on hemolytic hyperbilirubinemia-induced oxidative brain damage. J. Pineal Res. 60, 74\u201383 (2016).","journal-title":"J. Pineal Res."},{"key":"1556_CR118","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1177\/1933719115612132","volume":"23","author":"L Marseglia","year":"2016","unstructured":"Marseglia, L., D\u2019Angelo, G., Manti, S., Reiter, R. J. & Gitto, E. Potential utility of melatonin in preeclampsia, intrauterine fetal growth retardation, and perinatal asphyxia. Reprod. Sci. 23, 970\u2013977 (2016).","journal-title":"Reprod. Sci."},{"key":"1556_CR119","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/jpi.12121","volume":"56","author":"SL Miller","year":"2014","unstructured":"Miller, S. L. et al. Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. J. Pineal Res. 56, 283\u2013294 (2014).","journal-title":"J. Pineal Res."},{"key":"1556_CR120","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3109\/14767058.2015.1015417","volume":"29","author":"Y Wang","year":"2016","unstructured":"Wang, Y., Fu, W. & Liu, J. Neurodevelopment in children with intrauterine growth restriction: adverse effects and interventions. J. Matern. Fetal Neonatal Med. 29, 660\u2013668 (2016).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1556_CR121","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.smrv.2015.04.001","volume":"26","author":"SR Yiallourou","year":"2016","unstructured":"Yiallourou, S. R., Wallace, E. M., Miller, S. L. & Horne, R. S. Effects of intrauterine growth restriction on sleep and the cardiovascular system: the use of melatonin as a potential therapy? Sleep Med. Rev. 26, 64\u201373 (2016).","journal-title":"Sleep Med. Rev."},{"key":"1556_CR122","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/bcp.12092","volume":"76","author":"NM Merchant","year":"2013","unstructured":"Merchant, N. M. et al. Pharmacokinetics of melatonin in preterm infants. Br. J. Clin. Pharmacol. 76, 725\u2013733 (2013).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"1556_CR123","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3390\/molecules22122115","volume":"22","author":"Silvia Carloni","year":"2017","unstructured":"Carloni, S. et al. Melatonin pharmacokinetics following oral administration in preterm neonates. Molecules 22, 2115 (2017).","journal-title":"Molecules"},{"key":"1556_CR124","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00401-017-1718-6","volume":"134","author":"SA Back","year":"2017","unstructured":"Back, S. A. White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol. 134, 331\u2013349 (2017).","journal-title":"Acta Neuropathol."},{"key":"1556_CR125","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/dmcn.12415","volume":"56","author":"V Biran","year":"2014","unstructured":"Biran, V. et al. Is melatonin ready to be used in preterm infants as a neuroprotectant? Dev. Med. Child Neurol. 56, 717\u2013723 (2014).","journal-title":"Dev. Med. Child Neurol."},{"key":"1556_CR126","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1203\/PDR.0b013e3181fcb40b","volume":"69","author":"S Villapol","year":"2011","unstructured":"Villapol, S. et al. Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke. Pediatr. Res. 69, 51\u201355 (2011).","journal-title":"Pediatr. Res."},{"key":"1556_CR127","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jpeds.2017.08.005","volume":"189","author":"JL Aschner","year":"2017","unstructured":"Aschner, J. L., Bancalari, E. H. & McEvoy, C. T. Can we prevent bronchopulmonary dysplasia? J. Pediatr. 189, 26\u201330 (2017).","journal-title":"J. Pediatr."},{"key":"1556_CR128","first-page":"17","volume":"24","author":"JA Voynow","year":"2017","unstructured":"Voynow, J. A. \u201cNew\u201d bronchopulmonary dysplasia and chronic lung disease. Paediatr. Respir. Rev. 24, 17\u201318 (2017).","journal-title":"Paediatr. Respir. Rev."},{"key":"1556_CR129","doi-asserted-by":"publisher","first-page":"721043","DOI":"10.1155\/2014\/721043","volume":"2014","author":"C Poggi","year":"2014","unstructured":"Poggi, C. & Dani, C. Antioxidant strategies and respiratory disease of the preterm newborn: an update. Oxid. Med. Cell Longev. 2014, 721043 (2014).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1556_CR130","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-079X.2004.00124.x","volume":"36","author":"E Gitto","year":"2004","unstructured":"Gitto, E. et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J. Pineal Res. 36, 250\u2013255 (2004).","journal-title":"J. Pineal Res."},{"key":"1556_CR131","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1600-079X.2005.00251.x","volume":"39","author":"E Gitto","year":"2005","unstructured":"Gitto, E. et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J. Pineal Res. 39, 287\u2013293 (2005).","journal-title":"J. Pineal Res."},{"key":"1556_CR132","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000444918","volume":"110","author":"SK Barton","year":"2016","unstructured":"Barton, S. K. et al. Ventilation-induced brain injury in preterm neonates: a review of potential therapies. Neonatology 110, 155\u2013162 (2016).","journal-title":"Neonatology"},{"key":"1556_CR133","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14737175.2017.1259567","volume":"17","author":"EP Yildiz","year":"2017","unstructured":"Yildiz, E. P., Ekici, B. & Tatli, B. Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev. Neurother. 17, 449\u2013459 (2017).","journal-title":"Expert Rev. Neurother."},{"key":"1556_CR134","doi-asserted-by":"publisher","first-page":"F346","DOI":"10.1136\/archdischild-2015-309639","volume":"102","author":"K Martinello","year":"2017","unstructured":"Martinello, K., Hart, A. R., Yap, S., Mitra, S. & Robertson, N. J. Management and investigation of neonatal encephalopathy: 2017 update. Arch. Dis. Child Fetal Neonatal Ed. 102, F346\u2013F358 (2017).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"1556_CR135","doi-asserted-by":"publisher","first-page":"F541","DOI":"10.1136\/archdischild-2014-306284","volume":"100","author":"KJ Hassell","year":"2015","unstructured":"Hassell, K. J., Ezzati, M., Alonso-Alconada, D., Hausenloy, D. J. & Robertson, N. J. New horizons for newborn brain protection: enhancing endogenous neuroprotection. Arch. Dis. Child Fetal Neonatal Ed. 100, F541\u2013F552 (2015).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"1556_CR136","unstructured":"Wang, Q., Lv, H., Lu, L., Ren, P. & Li, L. Neonatal hypoxic-ischemic encephalopathy: emerging therapeutic strategies based on pathophysiologic phases of the injury. J. Matern. Fetal Neonatal Med., 2, 1\u20138 (2018)."},{"key":"1556_CR137","doi-asserted-by":"publisher","first-page":"22368","DOI":"10.3390\/ijms160922368","volume":"16","author":"BJ Dixon","year":"2015","unstructured":"Dixon, B. J., Reis, C., Ho, W. M., Tang, J. & Zhang, J. H. Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy. Int. J. Mol. Sci. 16, 22368\u201322401 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"1556_CR138","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.clinthera.2006.09.005","volume":"28","author":"JM Perlman","year":"2006","unstructured":"Perlman, J. M. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin. Ther. 28, 1353\u20131365 (2006).","journal-title":"Clin. Ther."},{"key":"1556_CR139","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clp.2016.04.007","volume":"43","author":"RM McAdams","year":"2016","unstructured":"McAdams, R. M. & Juul, S. E. Neonatal encephalopathy: update on therapeutic hypothermia and other novel therapeutics. Clin. Perinatol. 43, 485\u2013500 (2016).","journal-title":"Clin. Perinatol."},{"key":"1556_CR140","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2017.01.005","volume":"104","author":"E Ramos","year":"2017","unstructured":"Ramos, E. et al. Ischemic brain injury: new insights on the protective role of melatonin. Free Radic. Biol. Med. 104, 32\u201353 (2017).","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl 1","key":"1556_CR141","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/14767058.2012.663232","volume":"25","author":"W Balduini","year":"2012","unstructured":"Balduini, W. et al. The use of melatonin in hypoxic-ischemic brain damage: an experimental study. J. Matern. Fetal Neonatal Med. 25(Suppl 1), 119\u2013124 (2012).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1556_CR142","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.siny.2010.02.002","volume":"15","author":"MR Cilio","year":"2010","unstructured":"Cilio, M. R. & Ferriero, D. M. Synergistic neuroprotective therapies with hypothermia. Semin. Fetal Neonatal Med. 15, 293\u2013298 (2010).","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"Suppl 3.","key":"1556_CR143","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/14767058.2010.505052","volume":"23","author":"X Fan","year":"2010","unstructured":"Fan, X. & van Bel, F. Pharmacological neuroprotection after perinatal asphyxia. J. Matern. Fetal Neonatal Med. 23(Suppl 3.), 17\u201319 (2010).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1556_CR144","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jpeds.2017.08.031","volume":"192","author":"P Parikh","year":"2018","unstructured":"Parikh, P. & Juul, S. E. Neuroprotective strategies in neonatal brain injury. J. Pediatr. 192, 22\u201332 (2018).","journal-title":"J. Pediatr."},{"key":"1556_CR145","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/ACO.0000000000000184","volume":"28","author":"KL Shea","year":"2015","unstructured":"Shea, K. L. & Palanisamy, A. What can you do to protect the newborn brain? Curr. Opin. Anaesthesiol. 28, 261\u2013266 (2015).","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"1556_CR146","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.3390\/ijms14059379","volume":"14","author":"D Alonso-Alconada","year":"2013","unstructured":"Alonso-Alconada, D., Alvarez, A., Arteaga, O., Martinez-Ibarguen, A. & Hilario, E. Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. Int. J. Mol. Sci. 14, 9379\u20139395 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"1556_CR147","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/jp.2014.186","volume":"35","author":"H Aly","year":"2015","unstructured":"Aly, H. et al. Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J. Perinatol. 35, 186\u2013191 (2015).","journal-title":"J. Perinatol."},{"key":"1556_CR148","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1034\/j.1600-079X.2001.310409.x","volume":"31","author":"F Fulia","year":"2001","unstructured":"Fulia, F. et al. Increased levels of malondialdehyde and nitrite\/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J. Pineal Res. 31, 343\u2013349 (2001).","journal-title":"J. Pineal Res."},{"key":"1556_CR149","first-page":"1233","volume":"68","author":"QM Ahmad","year":"2018","unstructured":"Ahmad, Q. M., Chishti, A. L. & Waseem, N. Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: a randomized control trial. J. Pak. Med. Assoc. 68, 1233\u20131237 (2018).","journal-title":"J. Pak. Med. Assoc."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1556-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T14:12:41Z","timestamp":1721139161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1556-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":149,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1556-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}